Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Journal of Clinical Medicine|July 24, 2021
Chemotherapy for Biliary Tract Cancer in 2021Takashi Sasaki, Tsuyoshi Takeda, Takeshi Okamoto, et al.
In Vivo (Athens, Greece)|December 28, 2018
Improvement of Treatment Outcomes for Metastatic Pancreatic Cancer: A Real-world Data AnalysisTakashi Sasaki, Ryo Kanata, Ikuhiro Yamada, et al.
Plos One|July 3, 2020
Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasisYasunori Uesato, Naoki Sasahira, Masato Ozaka, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 7, 2014
[FOLFIRINOX-induced hyperammonemic encephalopathy in a patient with pancreatic cancer]Ikuhiro Yamada, Masato Ozaka, Hiroshi Ishii, et al.
Drug Design, Development and Therapy|July 1, 2015
Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN studyMitsukuni Suenaga, Nobuyuki Mizunuma, Satoshi Matsusaka, et al.
Japanese Journal of Clinical Oncology|October 8, 2010
Outcomes and tolerability of systemic chemotherapy for pancreatic or biliary cancer patients aged 75 years or olderSeigo Yukisawa, Hiroshi Ishii, Masato Matsuyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 18, 2014
[Neuroendocrine gallbladder cancer treated with cisplatin plus irinotecan - a case report]Dai Inoue, Masato Ozaka, Yusuke Muramatsu, et al.
European Journal of Gastroenterology & Hepatology|February 15, 2012
A transcatheter arterial chemotherapy using a novel lipophilic platinum derivative (miriplatin) for patients with small and multiple hepatocellular carcinomasSeigo Yukisawa, Hiroshi Ishii, Akiyoshi Kasuga, et al.
Cancers|March 13, 2024
Current Status of Targeted Therapy for Biliary Tract Cancer in the Era of Precision MedicineTakafumi Mie, Takashi Sasaki, Takeshi Okamoto, et al.
Pageof 18